event tracking

Clinical Trials

33 results.

May 14, 2017 VARI cancer researcher elected to National Academy of Sciences

GRAND RAPIDS, Mich. (May 15, 2017) — Stephen Baylin, M.D., Director’s Scholar and professor in the Center of Epigenetics at

March 6, 2017 New drug combination targets aggressive blood cancer

Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial

GRAND RAPIDS, Mich. (March 7,…

December 29, 2016 What difference does a year make?

When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…

December 7, 2016 New hope for Parkinson’s disease

For the estimated between 7 million and 10 million people living with Parkinson’s disease, there’s new reason for hope: Van Andel Research…

December 6, 2016 Diabetes drug slows experimental Parkinson’s disease progression, human trials to begin next year

GRAND RAPIDS, Mich. (Dec. 7, 2016)—A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of…

VAI DEFAULT HEADER
September 7, 2016 Diabetes drug focus of new clinical trial for Parkinson’s disease

HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…

VAI DEFAULT HEADER
April 3, 2016 Infographic: Seven Parkinson's terms to know

Parkinson’s is a progressive disease caused by the abnormal clumping of a protein in brain cells, some of which produce a chemical called dopamine that…

VAI DEFAULT HEADER
February 21, 2016 Promising respiratory drug focus of new clinical trial for Parkinson’s disease

GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus…